Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.
Nature Medicine|September 24, 2015
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variantsSándor Spisák, Kate Lawrenson, Yanfang Fu, et al.
Scientific Data|November 12, 2020
DISPERSE, a trait database to assess the dispersal potential of European aquatic macroinvertebratesRomain Sarremejane, Núria Cid, Rachel Stubbington, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Cancers|November 17, 2020
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8<sup>+</sup> T Cells in Non-Melanoma Cancers Compared to MelanomaAishwarya Gokuldass, Arianna Draghi, Krisztian Papp, et al.
Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.
Scientific Data|May 10, 2023
In-depth Temporal Transcriptome Profiling of Monkeypox and Host Cells using Nanopore SequencingBalázs Kakuk, Ákos Dörmő, Zsolt Csabai, et al.
NPJ Precision Oncology|April 8, 2024
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Nature Communications|August 23, 2023
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locusSandor Spisak, Viktoria Tisza, Pier Vitale Nuzzo, et al.
Pageof 29